790 related articles for article (PubMed ID: 19543052)
1. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model.
Kuo YR; Goto S; Shih HS; Wang FS; Lin CC; Wang CT; Huang EY; Chen CL; Wei FC; Zheng XX; Lee WP
Transplantation; 2009 Jun; 87(12):1769-77. PubMed ID: 19543052
[TBL] [Abstract][Full Text] [Related]
2. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
4. Prolongation of composite tissue allotransplant survival by treatment with bone marrow mesenchymal stem cells is correlated with T-cell regulation in a swine hind-limb model.
Kuo YR; Chen CC; Shih HS; Goto S; Huang CW; Wang CT; Chen CL; Wei FC
Plast Reconstr Surg; 2011 Feb; 127(2):569-579. PubMed ID: 21285761
[TBL] [Abstract][Full Text] [Related]
5. The effect of A2A adenosine receptor agonist on composite tissue allotransplant survival: an in vivo preliminary study.
Ulusal BG; Ulusal AE; Hung LM; Wei FC
J Surg Res; 2006 Apr; 131(2):261-6. PubMed ID: 16457843
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-derived mesenchymal stem cells inhibit acute rejection of rat liver allografts in association with regulatory T-cell expansion.
Wang Y; Zhang A; Ye Z; Xie H; Zheng S
Transplant Proc; 2009 Dec; 41(10):4352-6. PubMed ID: 20005397
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory effects of bone marrow-derived mesenchymal stem cells in a swine hemi-facial allotransplantation model.
Kuo YR; Chen CC; Goto S; Huang YT; Wang CT; Tsai CC; Chen CL
PLoS One; 2012; 7(4):e35459. PubMed ID: 22558153
[TBL] [Abstract][Full Text] [Related]
8. [Experiment study of efficacy on hematopoietic reconstitution and GVHD prophylaxis after mesenchymal cell infused by intra-bone marrow cavity or intravenous in rat BMT models].
Huang K; Huang SL; Zhou DH; Cai Y; Zhang XC; Li Y
Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):87-92. PubMed ID: 17650667
[TBL] [Abstract][Full Text] [Related]
9. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
10. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
11. Role of thymus in operational tolerance induction in limb allograft transplant model.
Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y; Deng YB; Huang YJ; Wang Y
Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
[TBL] [Abstract][Full Text] [Related]
13. Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model.
Sbano P; Cuccia A; Mazzanti B; Urbani S; Giusti B; Lapini I; Rossi L; Abbate R; Marseglia G; Nannetti G; Torricelli F; Miracco C; Bosi A; Fimiani M; Saccardi R
Arch Dermatol Res; 2008 Mar; 300(3):115-24. PubMed ID: 18259766
[TBL] [Abstract][Full Text] [Related]
14. Recipient Adipose-Derived Stem Cells Enhance Recipient Cell Engraftment and Prolong Allotransplant Survival in a Miniature Swine Hind-Limb Model.
Kuo YR; Chen CC; Chen YC; Chien CM
Cell Transplant; 2017 Aug; 26(8):1418-1427. PubMed ID: 28901186
[TBL] [Abstract][Full Text] [Related]
15. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus versus cyclosporine induction therapy in pulmonary transplantation in miniature swine.
Warnecke G; Avsar M; Steinkamp T; Reinhard R; Niedermeyer J; Simon AR; Haverich A; StrĂ¼ber M
Eur J Cardiothorac Surg; 2005 Sep; 28(3):454-60. PubMed ID: 16054825
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets.
Lu X; Liu T; Gu L; Huang C; Zhu H; Meng W; Xi Y; Li S; Liu Y
Transpl Immunol; 2009 Dec; 22(1-2):55-61. PubMed ID: 19695330
[TBL] [Abstract][Full Text] [Related]
18. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
Du B; Li DP; Xu KL; Pan XY
Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
[TBL] [Abstract][Full Text] [Related]
19. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier.
Siemionow MZ; Klimczak A; Unal S
Transplant Proc; 2005; 37(1):62-4. PubMed ID: 15808547
[TBL] [Abstract][Full Text] [Related]
20. Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft.
Zhou HP; Yi DH; Yu SQ; Sun GC; Cui Q; Zhu HL; Liu JC; Zhang JZ; Wu TJ
Transplant Proc; 2006 Nov; 38(9):3046-51. PubMed ID: 17112896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]